ODT
Odonate Therapeutics, Inc. Common Stock
Delisted
ODT was delisted on the 14th of January, 2022.
95 hedge funds and large institutions have $1.29B invested in Odonate Therapeutics, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 34 increasing their positions, 32 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
62% less call options, than puts
Call options by funds: $1.42M | Put options by funds: $3.72M
Holders
95
Holding in Top 10
4
Calls
$1.42M
Puts
$3.72M
Top Buyers
| 1 | +$5.72M | |
| 2 | +$4.87M | |
| 3 | +$4.02M | |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$3.44M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$3.18M |
Top Sellers
| 1 | -$10.4M | |
| 2 | -$7.98M | |
| 3 | -$4.66M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$3.72M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.56M |